Scheduled removal of central venous catheters (CVC) to prevent CVC-related bloodstream infections in patients with hematological disease or autologous stem cell transplantation: a registry-based randomized simulation-study.
Adolescent
Adult
Aged
Aged, 80 and over
Catheter-Related Infections
/ epidemiology
Catheterization, Central Venous
/ adverse effects
Central Venous Catheters
/ adverse effects
Female
Hematologic Neoplasms
/ therapy
Hematopoietic Stem Cell Transplantation
/ adverse effects
Humans
Male
Middle Aged
Registries
Sepsis
Transplantation, Autologous
Young Adult
Central venous catheter
Central venous catheter–related bloodstream infection
Hematology
Prevention
Registry-based randomized simulation-study
Scheduled removal
Journal
Annals of hematology
ISSN: 1432-0584
Titre abrégé: Ann Hematol
Pays: Germany
ID NLM: 9107334
Informations de publication
Date de publication:
Oct 2022
Oct 2022
Historique:
received:
02
04
2022
accepted:
13
08
2022
pubmed:
18
8
2022
medline:
14
9
2022
entrez:
17
8
2022
Statut:
ppublish
Résumé
Although not generally recommended, scheduled central venous catheter (CVC) removal is sometimes carried out in order to reduce the CVC-related bloodstream infection (CRBSI) incidence. We conducted a simulation for scheduled CVC removal within the multicenter CRBSI registry (SECRECY). Non-tunneled jugular and subclavian CVC in patients with hematological disease or with germ cell tumors (including patients receiving autologous stem cell transplantation [SCT]) were included. Cases were randomized in a 1:1:1:1 ratio to either a simulated, scheduled CVC removal after 7, 14, and 21 days, or to non-simulated, unscheduled CVC removal (control group). The primary endpoint was definitive CRBSI incidence for a scheduled CVC removal after 14 days (dCRBSI-D14
Identifiants
pubmed: 35978182
doi: 10.1007/s00277-022-04958-w
pii: 10.1007/s00277-022-04958-w
pmc: PMC9463193
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
2317-2324Informations de copyright
© 2022. The Author(s).
Références
O’Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, Lipsett PA, Masur H, Mermel LA, Pearson ML, Raad II, Randolph AG, Rupp ME, Saint S, Healthcare Infection Control Practices Advisory Committee (HICPAC) (2011) Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 52:e162–e193. https://doi.org/10.1093/cid/cir25
doi: 10.1093/cid/cir25
pubmed: 21460264
pmcid: 3106269
Zakhour R, Chaftari AM, Raad II (2016) Catheter-related infections in patients with haematological malignancies: novel preventive and therapeutic strategies. Lancet Infect Dis 16:e241–e250. https://doi.org/10.1016/S1473-3099(16)30213-4
doi: 10.1016/S1473-3099(16)30213-4
pubmed: 27788992
Böll B, Schalk E, Buchheidt D, Hasenkamp J, Kiehl M, Kiderlen TR, Kochanek M, Koldehoff M, Kostrewa P, Claßen AJ, Mellinghoff SC, Metzner B, Penack O, Ruhnke M, Vehreschild MJGT, Weissinger F, Wolf HH, Karthaus M, Hentrich M (2021) Central venous catheter-related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Hematol 100:239–259. https://doi.org/10.1007/s00277-020-04286-x
doi: 10.1007/s00277-020-04286-x
pubmed: 32997191
Safdar N, Kluger DM, Maki DG (2002) A review of risk factors for catheter-related bloodstream infection caused by percutaneously inserted, noncuffed central venous catheters: implications for preventive strategies. Medicine (Baltimore) 81:466–479. https://doi.org/10.1097/00005792-200211000-00007
doi: 10.1097/00005792-200211000-00007
Beekmann SE, Henderson DK (2015) Infections caused by percutaneous intravascular devices. In: Bennett JE, Dolin R, Blaser MJ (eds) Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, 8th edn. Elsevier, Philadelphia, pp 3310–3324
doi: 10.1016/B978-1-4557-4801-3.00302-7
Elishoov H, Or R, Strauss N, Engelhard D (1998) Nosocomial colonization, septicemia, and Hickman/Broviac catheter-related infections in bone marrow transplant recipients. A 5-year prospective study. Medicine (Baltimore) 77:83–101. https://doi.org/10.1097/00005792-199803000-00002
doi: 10.1097/00005792-199803000-00002
Howell PB, Walters PE, Donowitz DR, Farr BM (1995) Risk factors for infection of adult patients with cancer who have tunnelled central venous catheters. Cancer 75:1367–1375. https://doi.org/10.1002/1097-0142(19950315)75:6%3c1367::aid-cncr2820750620%3e3.0.co;2-z
doi: 10.1002/1097-0142(19950315)75:6<1367::aid-cncr2820750620>3.0.co;2-z
pubmed: 7882288
Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB (2003) Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis 36:1103–1110. https://doi.org/10.1086/374339
doi: 10.1086/374339
pubmed: 12715303
Biehl LM, Huth A, Panse J, Krämer C, Hentrich M, Engelhardt M, Schäfer-Eckart K, Kofla G, Kiehl M, Wendtner CM, Karthaus M, Ullmann AJ, Hellmich M, Christ H, Vehreschild MJGT (2016) A randomized trial on chlorhexidine dressings for the prevention of catheter-related bloodstream infections in neutropenic patients. Ann Oncol 27:1916–1922. https://doi.org/10.1093/annonc/mdw275
doi: 10.1093/annonc/mdw275
pubmed: 27456299
[No authors listed] Prävention von Infektionen, die von Gefäßkathetern ausgehen: Teil 1 – Nichtgetunnelte zentralvenöse Katheter Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) beim Robert Koch-Institut (2017) Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 60:171–206. https://doi.org/10.1007/s00103-016-2487-4
Ullman RF, Gurevich I, Schoch PE, Cunha BA (1990) Colonization and bacteremia related to duration of triple-lumen intravascular catheter placement. Am J Infect Control 18:201–207. https://doi.org/10.1016/0196-6553(90)90185-u
doi: 10.1016/0196-6553(90)90185-u
pubmed: 2363540
Morzaria P, Carle C (2021) Should central venous catheters be routinely replaced in adults? Br J Hosp Med (Lond) 82:1–2. https://doi.org/10.12968/hmed.2020.0711
doi: 10.12968/hmed.2020.0711
Cobb DK, High KP, Sawyer RG, Sable CA, Adams RB, Lindley DA, Pruett TL, Schwenzer KJ, Farr BM (1992) A controlled trial of scheduled replacement of central venous and pulmonary-artery catheters. N Engl J Med 327:1062–1068. https://doi.org/10.1056/NEJM199210083271505
doi: 10.1056/NEJM199210083271505
pubmed: 1522842
Cook D, Randolph A, Kernerman P, Cupido C, King D, Soukup C, Brun-Buisson C (1997) Central venous catheter replacement strategies: a systematic review of the literature. Crit Care Med 25:1417–1424. https://doi.org/10.1097/00003246-199708000-00033
doi: 10.1097/00003246-199708000-00033
pubmed: 9267959
McLaws ML, Berry G (2005) Nonuniform risk of bloodstream infection with increasing central venous catheter-days. Infect Control Hosp Epidemiol 26:715–719. https://doi.org/10.1086/502608
doi: 10.1086/502608
pubmed: 16156329
Schalk E, Biehl LM, Färber J, Schlüter D, Vehreschild MJGT, Fischer T (2017) Determination of a cutoff time point for prophylactic exchange of central venous catheters for prevention of central venous catheter-related bloodstream infections in patients with hematological malignancies. Infect Control Hosp Epidemiol 38:888–889. https://doi.org/10.1017/ice.2017.92
doi: 10.1017/ice.2017.92
pubmed: 28514979
Wu O, McCartney E, Heggie R, Germeni E, Paul J, Soulis E, Dillon D, Ryan C, Sim M, Dixon-Hughes J, Agarwal R, Bodenham A, Menne T, Jones B, Moss J (2021) Venous access devices for the delivery of long-term chemotherapy: the CAVA three-arm RCT. Health Technol Assess 25:1–126. https://doi.org/10.3310/hta25470
doi: 10.3310/hta25470
pubmed: 34318743
Schalk E, Hanus L, Färber J, Fischer T, Heidel FH (2015) Prediction of central venous catheter-related bloodstream infections (CRBSIs) in patients with haematologic malignancies using a modified Infection Probability Score (mIPS). Ann Hematol 94:1451–1456. https://doi.org/10.1007/s00277-015-2387-y
doi: 10.1007/s00277-015-2387-y
pubmed: 25933677
Hentrich M, Schalk E, Schmidt-Hieber M, Chaberny I, Mousset S, Buchheidt D, Ruhnke M, Penack O, Salwender H, Wolf HH, Christopeit M, Neumann S, Maschmeyer G, Karthaus M, Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (2014) Central venous catheter-related infections in hematology and oncology: 2012 updated guidelines on diagnosis, management and prevention by the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology. Ann Oncol 25:936–947. https://doi.org/10.1093/annonc/mdt545
doi: 10.1093/annonc/mdt545
pubmed: 24399078
Dafni U (2011) Landmark analysis at the 25-year landmark point. Circ Cardiovasc Qual Outcomes 4:363–371. https://doi.org/10.1161/CIRCOUTCOMES.110.957951
doi: 10.1161/CIRCOUTCOMES.110.957951
pubmed: 21586725
Bouza E, Burillo A, Muñoz P (2002) Catheter-related infections: diagnosis and intravascular treatment. Clin Microbiol Infect 8:265–274. https://doi.org/10.1046/j.1469-0691.2002.00385.x
doi: 10.1046/j.1469-0691.2002.00385.x
pubmed: 12047403
Campbell I (2007) Chi-squared and Fisher-Irwin tests of two-by-two tables with small sample recommendations. Stat Med 26:3661–3675. https://doi.org/10.1002/sim.2832
doi: 10.1002/sim.2832
pubmed: 17315184
Richardson JTE (2011) The analysis of 2 × 2 contingency tables--yet again. Stat Med 30:890; author reply 891–2. https://doi.org/10.1002/sim.4116
Citrome L (2008) Compelling or irrelevant? Using number needed to treat can help decide. Acta Psychiatr Scand 117:412–419. https://doi.org/10.1111/j.1600-0447.2008.01194.x
doi: 10.1111/j.1600-0447.2008.01194.x
pubmed: 18479317
Takashima T, Schults J, Mihala G, Corley A, Ullman A (2018) Complication and failures of central vascular access device in adult critical care settings. Crit Care Med 46:1998–2009. https://doi.org/10.1097/CCM.0000000000003370
doi: 10.1097/CCM.0000000000003370
pubmed: 30095499
Schmid C, Schleuning M, Ledderose G, Tischer J, Kolb HJ (2005) Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome. J Clin Oncol 23:5675–5687. https://doi.org/10.1200/JCO.2005.07.061
doi: 10.1200/JCO.2005.07.061
pubmed: 16110027
Tomlinson D, Mermel LA, Ethier MC, Matlow A, Gillmeister B, Sung L (2011) Defining bloodstream infections related to central venous catheters in patients with cancer: a systematic review. Clin Infect Dis 53(7):697–710. https://doi.org/10.1093/cid/cir523
doi: 10.1093/cid/cir523
pubmed: 21890775
Schalk E, Teschner D, Hentrich M, Böll B, Panse J, Schmidt-Hieber M, Vehreschild MJGT, Biehl LM (2020) Central venous catheter-related bloodstream infections in patients with hematological malignancies: comparison of data from a clinical registry and a randomized controlled trial. Infect Control Hosp Epidemiol 41:254–256. https://doi.org/10.1017/ice.2019.335
doi: 10.1017/ice.2019.335
pubmed: 31818338
Schalk E, Vehreschild MJGT, Biehl LM (2021) Influence of different definitions of central venous catheter-related bloodstream infections on epidemiological parameters in cancer patients. Infect Control Hosp Epidemiol 42:501–503. https://doi.org/10.1017/ice.2020.274
doi: 10.1017/ice.2020.274
pubmed: 32631475
Tölle D, Hentrich M, Pelzer BW, Kremer P, Einhell S, Schulz S, Böll B, Panse J, Schmidt-Hieber M, Teschner D, Schalk E (2019) Impact of neutropenia on central venous catheter-related bloodstream infections in patients with hematological malignancies at the time of central venous catheter insertion: A matched-pair analysis. Infect Control Hosp Epidemiol 40:1204–1206. https://doi.org/10.1017/ice.2019.224
doi: 10.1017/ice.2019.224
pubmed: 31352911
Zeidler K, Arn K, Senn O, Schanz U, Stussi G (2011) Optimal preprocedural platelet transfusion threshold for central venous catheter insertions in patients with thrombocytopenia. Transfusion 51:2269–2276. https://doi.org/10.1111/j.1537-2995.2011.03147.x
doi: 10.1111/j.1537-2995.2011.03147.x
pubmed: 21517892
Kaufman RM, Djulbegovic B, Gernsheimer T, Kleinman S, Tinmouth AT, Capocelli KE, Cipolle MD, Cohn CS, Fung MK, Grossman BJ, Mintz PD, O’Malley BA, Sesok-Pizzini DA, Shander A, Stack GE, Webert KE, Weinstein R, Welch BG, Whitman GJ, Wong EC, Tobian AAR, AABB, (2015) Platelet transfusion: a clinical practice guideline from the AABB. Ann Intern Med 162:205–213. https://doi.org/10.7326/M14-1589
doi: 10.7326/M14-1589
pubmed: 25383671
Raad S, Chaftari AM, Hachem RY, Shah P, Natividad E, Cleeland CS, Rosenblatt J (2018) Removal and insertion of central venous catheters in cancer patients is associated with high symptom burden. Expert Rev Med Devices 15:591–596. https://doi.org/10.1080/17434440.2018.1500892
doi: 10.1080/17434440.2018.1500892
pubmed: 30067125
Li G, Sajobi TT, Menon BK, Korngut L, Lowerison M, James M, Wilton SB, Williamson T, Gill S, Drogos LL, Smith EE, Vohra S, Hill MD, Thabane L (2016) Symposium on Registry-Based Randomized Controlled Trials in Calgary (2016) Registry-based randomized controlled trials- what are the advantages, challenges, and areas for future research? J Clin Epidemiol 80:16–24. https://doi.org/10.1016/j.jclinepi.2016.08.003
doi: 10.1016/j.jclinepi.2016.08.003
pubmed: 27555082